Hospital use, associated costs, and payer status for infants born with spina bifida

Elizabeth Radcliff1, Cynthia H Cassell, Jean Paul Tanner

  • 1Department of Public Health Sciences, University of North Carolina at Charlotte, Charlotte, North Carolina 28223, USA. eradclif@uncc.edu

Insights

A small group of infants with spina bifida (SB) experience multiple hospitalizations and high healthcare costs within their first year. Public payers covered nearly 60% of these hospitalizations.

Area of Science:

  • Pediatric Health Outcomes
  • Public Health Policy
  • Healthcare Economics

Background:

  • Children with spina bifida (SB) incur higher healthcare utilization and costs than unaffected children.
  • Limited data exists on hospital use and associated costs for infants with SB across different health insurance payer types.
  • Understanding these costs is crucial for resource allocation and policy development.

Purpose of the Study:

  • To examine hospitalizations and associated costs in the first year of life for infants with spina bifida (SB).
  • To analyze these costs based on sociodemographic characteristics and health insurance payer types.
  • To investigate changes in health insurance payer status among these infants.

Main Methods:

  • Retrospective, population-based analysis of Florida infants born with SB (1998-2007).
  • Data linkage between the Florida Birth Defects Registry and hospital discharge records.
  • Calculation of hospitalizations, length of stay, and estimated costs, stratified by demographics and payer type.

Main Results:

  • 615 infants with SB averaged 2.4 hospitalizations and 25.2 days in the hospital during their first year.
  • Approximately 18% of infants had over three hospitalizations.
  • Public payer sources covered almost 60% of hospitalizations, with mean costs of $39,059 per infant.

Conclusions:

  • A small proportion of infants with spina bifida account for a significant number of hospitalizations and high costs.
  • Further research is needed to identify factors influencing length of stay, hospitalization frequency, and overall costs.
  • Findings highlight the substantial economic burden associated with SB care in infancy.
Abstract

Related Concept Videos

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic01:26

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
Neurulation01:30

Neurulation

Neurulation is the embryological process which forms the precursors of the central nervous system and occurs after gastrulation has established the three primary cell layers of the embryo: ectoderm, mesoderm, and endoderm. In humans, the majority of this system is formed via primary neurulation, in which the central portion of the ectoderm—originally appearing as a flat sheet of cells—folds upwards and inwards, sealing off to form a hollow neural tube. As development proceeds, the anterior...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...